BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 15143855)

  • 1. Antibodies to molds and satratoxin in individuals exposed in water-damaged buildings.
    Vojdani A; Thrasher JD; Madison RA; Gray MR; Heuser G; Campbell AW
    Arch Environ Health; 2003 Jul; 58(7):421-32. PubMed ID: 15143855
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antibodies against molds and mycotoxins following exposure to toxigenic fungi in a water-damaged building.
    Vojdani A; Campbell AW; Kashanian A; Vojdani E
    Arch Environ Health; 2003 Jun; 58(6):324-36. PubMed ID: 14992307
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neural autoantibodies and neurophysiologic abnormalities in patients exposed to molds in water-damaged buildings.
    Campbell AW; Thrasher JD; Madison RA; Vojdani A; Gray MR; Johnson A
    Arch Environ Health; 2003 Aug; 58(8):464-74. PubMed ID: 15259425
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mixed mold mycotoxicosis: immunological changes in humans following exposure in water-damaged buildings.
    Gray MR; Thrasher JD; Crago R; Madison RA; Arnold L; Campbell AW; Vojdani A
    Arch Environ Health; 2003 Jul; 58(7):410-20. PubMed ID: 15143854
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Saliva secretory IgA antibodies against molds and mycotoxins in patients exposed to toxigenic fungi.
    Vojdani A; Kashanian A; Vojdani E; Campbell AW
    Immunopharmacol Immunotoxicol; 2003 Nov; 25(4):595-614. PubMed ID: 14686801
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Environmental mold and mycotoxin exposures elicit specific cytokine and chemokine responses.
    Rosenblum Lichtenstein JH; Hsu YH; Gavin IM; Donaghey TC; Molina RM; Thompson KJ; Chi CL; Gillis BS; Brain JD
    PLoS One; 2015; 10(5):e0126926. PubMed ID: 26010737
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immune response among patients exposed to molds.
    Edmondson DA; Barrios CS; Brasel TL; Straus DC; Kurup VP; Fink JN
    Int J Mol Sci; 2009 Dec; 10(12):5471-84. PubMed ID: 20054481
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antibodies against Stachybotrys chartarum extract and its antigenic components, Stachyhemolysin and Stachyrase-A: a new clinical biomarker.
    Vojdani A
    Med Sci Monit; 2005 May; 11(5):BR139-145. PubMed ID: 15874884
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection of trichothecene mycotoxins in sera from individuals exposed to Stachybotrys chartarum in indoor environments.
    Brasel TL; Campbell AW; Demers RE; Ferguson BS; Fink J; Vojdani A; Wilson SC; Straus DC
    Arch Environ Health; 2004 Jun; 59(6):317-23. PubMed ID: 16238166
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of toxic exposure to molds and mycotoxins in building-related illnesses.
    Rea WJ; Didriksen N; Simon TR; Pan Y; Fenyves EJ; Griffiths B
    Arch Environ Health; 2003 Jul; 58(7):399-405. PubMed ID: 15143852
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cross-reactivity of Aspergillus, Penicillium, and Stachybotrys antigens using affinity-purified antibodies and immunoassay.
    Vojdani A
    Arch Environ Health; 2004 May; 59(5):256-65. PubMed ID: 16201672
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Investigation of mold fungi in air samples of elementary schools and evaluation of allergen-specific IgE levels in students' sera].
    Ovet H; Ergin C; Kaleli I
    Mikrobiyol Bul; 2012 Apr; 46(2):266-75. PubMed ID: 22639315
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mold-specific immunoglobulin G antibodies in a child population.
    Korppi M; Laitinen S; Taskinen T; Reiman M; Nevalainen A; Husman T
    Pediatr Allergy Immunol; 2003 Oct; 14(5):371-7. PubMed ID: 14641607
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Health and immunology study following exposure to toxigenic fungi (Stachybotrys chartarum) in a water-damaged office environment.
    Johanning E; Biagini R; Hull D; Morey P; Jarvis B; Landsbergis P
    Int Arch Occup Environ Health; 1996; 68(4):207-18. PubMed ID: 8738349
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low tumor necrosis factor alpha levels and neutrophil counts in nasal lavage after mold exposure.
    Hellgren UM; Leino M; Aarnisalo AA; Mussalo-Rauhamaa H; Alenius H; Reijula K
    Ann Allergy Asthma Immunol; 2009 Mar; 102(3):210-5. PubMed ID: 19354067
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mould specific IgG antibodies connected with sinusitis in teachers of mould damaged school: a two-year follow-up study.
    Patovirta RL; Reiman M; Husman T; Haverinen U; Toivola M; Nevalainen A
    Int J Occup Med Environ Health; 2003; 16(3):221-30. PubMed ID: 14587535
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Large Case-series of Successful Treatment of Patients Exposed to Mold and Mycotoxin.
    Rea WJ
    Clin Ther; 2018 Jun; 40(6):889-893. PubMed ID: 29861191
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Indoor mold exposure associated with neurobehavioral and pulmonary impairment: a preliminary report.
    Kilburn KH
    Arch Environ Health; 2003 Jul; 58(7):390-8. PubMed ID: 15143851
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Serum levels of antibodies for IgG, IgA, and IgM against the fungi antigen in psoriasis vulgaris].
    Liang YS; Wen HQ; Xiao R
    Hunan Yi Ke Da Xue Xue Bao; 2003 Dec; 28(6):638-40. PubMed ID: 15804080
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of an LPS-based ELISA for diagnosis of Yersinia enterocolitica O:3 infections in Danish patients: a follow-up study.
    Dalby T; Rasmussen E; Schiellerup P; Krogfelt KA
    BMC Microbiol; 2017 May; 17(1):125. PubMed ID: 28545413
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.